Improving diabetes diagnosis and management in myocardial infarction patients: Overcoming clinical inertia

Abstract

Diabetes is underdiagnosed and undertreated among acute myocardial infarction (AMI) patients. The early diagnosis and treatment of diabetes during AMI facilitates improved risk stratification, use of appropriate revascularization strategies and secondary prevention medications, and timely initiation of glycemic therapy. Accurate diagnostic methods, such as hemoglobin A1c, should be evaluated for hospitalized AMI patients. In addition, efforts to improve the uptake of diabetes screening and management in the hospitalized setting should occur. Possible actions include the use of clinical information systems to generate physician reminders for diabetes detection and management, audit and feedback programs, and professional society initiatives to address diabetes screening and therapy initiation through clinical guidelines and performance measures. Through the application of both these and other efforts listed in the manuscript, the rates of undiagnosed and undertreated diabetes among AMI patients can be significantly reduced, which would lead to an improvement in both diabetic and cardiovascular outcomes.